Interferon Beta Drives Therapy Resistance in a Patient Derived Model of High Grade Serous Ovarian Cancer
Ashlyn Conant, Tise Suzuki, Kiera McGivney…·Juli Unternaehrer
This study shows that IFN-beta drives therapy resistance in HGSOC models through cell-autonomous signaling, independent of DNA damage.